Veeva Systems Inc. $VEEV Stock Holdings Decreased by Brown Capital Management LLC

Brown Capital Management LLC trimmed its position in Veeva Systems Inc. (NYSE:VEEV) by 14.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 556,852 shares of the technology company’s stock after selling 96,833 shares during the period. Veeva Systems makes up about 4.7% of Brown Capital Management LLC’s holdings, making the stock its 2nd biggest position. Brown Capital Management LLC’s holdings in Veeva Systems were worth $160,362,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in VEEV. Sigma Planning Corp lifted its position in Veeva Systems by 1.2% in the second quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock valued at $958,000 after purchasing an additional 39 shares during the period. Keybank National Association OH lifted its holdings in shares of Veeva Systems by 1.4% in the 2nd quarter. Keybank National Association OH now owns 3,088 shares of the technology company’s stock valued at $889,000 after buying an additional 42 shares during the period. Facet Wealth Inc. boosted its stake in shares of Veeva Systems by 3.3% in the second quarter. Facet Wealth Inc. now owns 1,342 shares of the technology company’s stock valued at $381,000 after buying an additional 43 shares in the last quarter. TFB Advisors LLC grew its holdings in Veeva Systems by 1.2% during the first quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock worth $831,000 after acquiring an additional 44 shares during the period. Finally, Triangle Securities Wealth Management raised its position in Veeva Systems by 0.8% in the second quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock worth $1,665,000 after acquiring an additional 45 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Stock Performance

Shares of NYSE:VEEV opened at $242.24 on Friday. The business’s fifty day moving average price is $281.00 and its two-hundred day moving average price is $278.57. The stock has a market cap of $39.82 billion, a PE ratio of 47.13, a price-to-earnings-growth ratio of 1.79 and a beta of 1.05. Veeva Systems Inc. has a one year low of $201.54 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.09. The business had revenue of $0.81 million for the quarter, compared to the consensus estimate of $792.37 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The business’s revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.75 earnings per share. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. As a group, equities research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Insider Transactions at Veeva Systems

In other news, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the transaction, the insider owned 25,325 shares of the company’s stock, valued at $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Jonathan Faddis sold 720 shares of the business’s stock in a transaction on Monday, October 6th. The shares were sold at an average price of $298.12, for a total value of $214,646.40. Following the completion of the transaction, the senior vice president owned 7,868 shares of the company’s stock, valued at $2,345,608.16. This trade represents a 8.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 over the last ninety days. 10.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

VEEV has been the subject of several recent analyst reports. Jefferies Financial Group reiterated a “buy” rating and issued a $330.00 price objective on shares of Veeva Systems in a research note on Monday, November 24th. Robert W. Baird lifted their price target on shares of Veeva Systems from $314.00 to $319.00 and gave the company an “outperform” rating in a research report on Friday, November 21st. Citigroup lowered their price target on Veeva Systems from $349.00 to $319.00 and set a “buy” rating on the stock in a report on Monday, November 24th. BMO Capital Markets began coverage on Veeva Systems in a research note on Thursday, November 13th. They issued a “market perform” rating and a $300.00 price objective for the company. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $325.00 price objective on shares of Veeva Systems in a report on Thursday, August 28th. Twenty investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $305.88.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.